Eintrag weiter verarbeiten
Ubiquinol Improves Symptoms in Children with Autism
Gespeichert in:
| Zeitschriftentitel: | Oxidative Medicine and Cellular Longevity |
|---|---|
| Personen und Körperschaften: | , , , , , |
| In: | Oxidative Medicine and Cellular Longevity, 2014, 2014, S. 1-6 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Hindawi Limited
|
| Schlagwörter: |
| author_facet |
Gvozdjáková, Anna Kucharská, Jarmila Ostatníková, Daniela Babinská, Katarína Nakládal, Dalibor Crane, Fred L. Gvozdjáková, Anna Kucharská, Jarmila Ostatníková, Daniela Babinská, Katarína Nakládal, Dalibor Crane, Fred L. |
|---|---|
| author |
Gvozdjáková, Anna Kucharská, Jarmila Ostatníková, Daniela Babinská, Katarína Nakládal, Dalibor Crane, Fred L. |
| spellingShingle |
Gvozdjáková, Anna Kucharská, Jarmila Ostatníková, Daniela Babinská, Katarína Nakládal, Dalibor Crane, Fred L. Oxidative Medicine and Cellular Longevity Ubiquinol Improves Symptoms in Children with Autism Cell Biology Aging General Medicine Biochemistry |
| author_sort |
gvozdjáková, anna |
| spelling |
Gvozdjáková, Anna Kucharská, Jarmila Ostatníková, Daniela Babinská, Katarína Nakládal, Dalibor Crane, Fred L. 1942-0900 1942-0994 Hindawi Limited Cell Biology Aging General Medicine Biochemistry http://dx.doi.org/10.1155/2014/798957 <jats:p><jats:italic>Background</jats:italic>. Autism is a spectrum of neurodevelopmental disorders with manifestation within 3 years after birth. Manifestations of autism include behavior problems (hyperactivity, toys destruction, self-harm, and agression) and sleep and eating disorders. Etiology of autism is poorly understood. Oxidative stress and antioxidants can participate in pathobiochemical mechanisms of autism.<jats:italic>Methods</jats:italic>. Twenty-four children, aged 3–6 years, with autism according to the DSM IV criteria and using CARS were included in the study. Concentrations of<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CoQ</mml:mtext></mml:mrow><mml:mrow><mml:mn mathvariant="normal">10</mml:mn><mml:mo>-</mml:mo><mml:mtext>TOTAL</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:math>,<jats:italic>γ</jats:italic>- and<jats:italic>α</jats:italic>-tocopherol,<jats:italic>β</jats:italic>-carotene, and lipid peroxidation were determined in plasma before and after three months of supportive therapy with ubiquinol at a daily dose<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M2"><mml:mn>2</mml:mn><mml:mo>×</mml:mo><mml:mn>50</mml:mn></mml:math> mg. Data on behavior of the children were collected from parents at the same time.<jats:italic>Results</jats:italic>. Ubiquinol supportive therapy improved symptoms in children with autism, as communication with parents (in<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M3"><mml:mn>12</mml:mn><mml:mi>%</mml:mi></mml:math>), verbal communication (in<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M4"><mml:mn>21</mml:mn><mml:mi>%</mml:mi></mml:math>), playing games of children (in<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M5"><mml:mn>42</mml:mn><mml:mi>%</mml:mi></mml:math>), sleeping (in<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M6"><mml:mn>34</mml:mn><mml:mi>%</mml:mi></mml:math>), and food rejection (in<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M7"><mml:mn>17</mml:mn><mml:mi>%</mml:mi></mml:math>), with<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M8"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CoQ</mml:mtext></mml:mrow><mml:mrow><mml:mn mathvariant="normal">10</mml:mn><mml:mo>-</mml:mo><mml:mtext>TOTAL</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:math>plasma level above<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M9"><mml:mn>2.5</mml:mn><mml:mo> </mml:mo><mml:mi>μ</mml:mi><mml:mtext>mol</mml:mtext><mml:mo>/</mml:mo><mml:mtext>L</mml:mtext></mml:math>.<jats:italic>Conclusions</jats:italic>. Beneficial effect of ubiquinol in children with autism has been demonstrated for the first time. We assume that plasma concentration of<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M10"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CoQ</mml:mtext></mml:mrow><mml:mrow><mml:mn mathvariant="normal">10</mml:mn><mml:mo>-</mml:mo><mml:mtext>TOTAL</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:math>and lipid peroxidation could be used as relevant biomarkers of ubiquinol supportive therapy.</jats:p> Ubiquinol Improves Symptoms in Children with Autism Oxidative Medicine and Cellular Longevity |
| doi_str_mv |
10.1155/2014/798957 |
| facet_avail |
Online Free |
| finc_class_facet |
Biologie Chemie und Pharmazie |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1NS8yMDE0Lzc5ODk1Nw |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1NS8yMDE0Lzc5ODk1Nw |
| institution |
DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 |
| imprint |
Hindawi Limited, 2014 |
| imprint_str_mv |
Hindawi Limited, 2014 |
| issn |
1942-0900 1942-0994 |
| issn_str_mv |
1942-0900 1942-0994 |
| language |
English |
| mega_collection |
Hindawi Limited (CrossRef) |
| match_str |
gvozdjakova2014ubiquinolimprovessymptomsinchildrenwithautism |
| publishDateSort |
2014 |
| publisher |
Hindawi Limited |
| recordtype |
ai |
| record_format |
ai |
| series |
Oxidative Medicine and Cellular Longevity |
| source_id |
49 |
| title |
Ubiquinol Improves Symptoms in Children with Autism |
| title_unstemmed |
Ubiquinol Improves Symptoms in Children with Autism |
| title_full |
Ubiquinol Improves Symptoms in Children with Autism |
| title_fullStr |
Ubiquinol Improves Symptoms in Children with Autism |
| title_full_unstemmed |
Ubiquinol Improves Symptoms in Children with Autism |
| title_short |
Ubiquinol Improves Symptoms in Children with Autism |
| title_sort |
ubiquinol improves symptoms in children with autism |
| topic |
Cell Biology Aging General Medicine Biochemistry |
| url |
http://dx.doi.org/10.1155/2014/798957 |
| publishDate |
2014 |
| physical |
1-6 |
| description |
<jats:p><jats:italic>Background</jats:italic>. Autism is a spectrum of neurodevelopmental disorders with manifestation within 3 years after birth. Manifestations of autism include behavior problems (hyperactivity, toys destruction, self-harm, and agression) and sleep and eating disorders. Etiology of autism is poorly understood. Oxidative stress and antioxidants can participate in pathobiochemical mechanisms of autism.<jats:italic>Methods</jats:italic>. Twenty-four children, aged 3–6 years, with autism according to the DSM IV criteria and using CARS were included in the study. Concentrations of<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CoQ</mml:mtext></mml:mrow><mml:mrow><mml:mn mathvariant="normal">10</mml:mn><mml:mo>-</mml:mo><mml:mtext>TOTAL</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:math>,<jats:italic>γ</jats:italic>- and<jats:italic>α</jats:italic>-tocopherol,<jats:italic>β</jats:italic>-carotene, and lipid peroxidation were determined in plasma before and after three months of supportive therapy with ubiquinol at a daily dose<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M2"><mml:mn>2</mml:mn><mml:mo>×</mml:mo><mml:mn>50</mml:mn></mml:math> mg. Data on behavior of the children were collected from parents at the same time.<jats:italic>Results</jats:italic>. Ubiquinol supportive therapy improved symptoms in children with autism, as communication with parents (in<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M3"><mml:mn>12</mml:mn><mml:mi>%</mml:mi></mml:math>), verbal communication (in<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M4"><mml:mn>21</mml:mn><mml:mi>%</mml:mi></mml:math>), playing games of children (in<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M5"><mml:mn>42</mml:mn><mml:mi>%</mml:mi></mml:math>), sleeping (in<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M6"><mml:mn>34</mml:mn><mml:mi>%</mml:mi></mml:math>), and food rejection (in<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M7"><mml:mn>17</mml:mn><mml:mi>%</mml:mi></mml:math>), with<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M8"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CoQ</mml:mtext></mml:mrow><mml:mrow><mml:mn mathvariant="normal">10</mml:mn><mml:mo>-</mml:mo><mml:mtext>TOTAL</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:math>plasma level above<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M9"><mml:mn>2.5</mml:mn><mml:mo> </mml:mo><mml:mi>μ</mml:mi><mml:mtext>mol</mml:mtext><mml:mo>/</mml:mo><mml:mtext>L</mml:mtext></mml:math>.<jats:italic>Conclusions</jats:italic>. Beneficial effect of ubiquinol in children with autism has been demonstrated for the first time. We assume that plasma concentration of<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M10"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CoQ</mml:mtext></mml:mrow><mml:mrow><mml:mn mathvariant="normal">10</mml:mn><mml:mo>-</mml:mo><mml:mtext>TOTAL</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:math>and lipid peroxidation could be used as relevant biomarkers of ubiquinol supportive therapy.</jats:p> |
| container_start_page |
1 |
| container_title |
Oxidative Medicine and Cellular Longevity |
| container_volume |
2014 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792346305073250312 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T17:37:16.363Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Ubiquinol+Improves+Symptoms+in+Children+with+Autism&rft.date=2014-01-01&genre=article&issn=1942-0994&volume=2014&spage=1&epage=6&pages=1-6&jtitle=Oxidative+Medicine+and+Cellular+Longevity&atitle=Ubiquinol+Improves+Symptoms+in+Children+with+Autism&aulast=Crane&aufirst=Fred+L.&rft_id=info%3Adoi%2F10.1155%2F2014%2F798957&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792346305073250312 |
| author | Gvozdjáková, Anna, Kucharská, Jarmila, Ostatníková, Daniela, Babinská, Katarína, Nakládal, Dalibor, Crane, Fred L. |
| author_facet | Gvozdjáková, Anna, Kucharská, Jarmila, Ostatníková, Daniela, Babinská, Katarína, Nakládal, Dalibor, Crane, Fred L., Gvozdjáková, Anna, Kucharská, Jarmila, Ostatníková, Daniela, Babinská, Katarína, Nakládal, Dalibor, Crane, Fred L. |
| author_sort | gvozdjáková, anna |
| container_start_page | 1 |
| container_title | Oxidative Medicine and Cellular Longevity |
| container_volume | 2014 |
| description | <jats:p><jats:italic>Background</jats:italic>. Autism is a spectrum of neurodevelopmental disorders with manifestation within 3 years after birth. Manifestations of autism include behavior problems (hyperactivity, toys destruction, self-harm, and agression) and sleep and eating disorders. Etiology of autism is poorly understood. Oxidative stress and antioxidants can participate in pathobiochemical mechanisms of autism.<jats:italic>Methods</jats:italic>. Twenty-four children, aged 3–6 years, with autism according to the DSM IV criteria and using CARS were included in the study. Concentrations of<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CoQ</mml:mtext></mml:mrow><mml:mrow><mml:mn mathvariant="normal">10</mml:mn><mml:mo>-</mml:mo><mml:mtext>TOTAL</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:math>,<jats:italic>γ</jats:italic>- and<jats:italic>α</jats:italic>-tocopherol,<jats:italic>β</jats:italic>-carotene, and lipid peroxidation were determined in plasma before and after three months of supportive therapy with ubiquinol at a daily dose<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M2"><mml:mn>2</mml:mn><mml:mo>×</mml:mo><mml:mn>50</mml:mn></mml:math> mg. Data on behavior of the children were collected from parents at the same time.<jats:italic>Results</jats:italic>. Ubiquinol supportive therapy improved symptoms in children with autism, as communication with parents (in<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M3"><mml:mn>12</mml:mn><mml:mi>%</mml:mi></mml:math>), verbal communication (in<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M4"><mml:mn>21</mml:mn><mml:mi>%</mml:mi></mml:math>), playing games of children (in<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M5"><mml:mn>42</mml:mn><mml:mi>%</mml:mi></mml:math>), sleeping (in<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M6"><mml:mn>34</mml:mn><mml:mi>%</mml:mi></mml:math>), and food rejection (in<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M7"><mml:mn>17</mml:mn><mml:mi>%</mml:mi></mml:math>), with<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M8"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CoQ</mml:mtext></mml:mrow><mml:mrow><mml:mn mathvariant="normal">10</mml:mn><mml:mo>-</mml:mo><mml:mtext>TOTAL</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:math>plasma level above<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M9"><mml:mn>2.5</mml:mn><mml:mo> </mml:mo><mml:mi>μ</mml:mi><mml:mtext>mol</mml:mtext><mml:mo>/</mml:mo><mml:mtext>L</mml:mtext></mml:math>.<jats:italic>Conclusions</jats:italic>. Beneficial effect of ubiquinol in children with autism has been demonstrated for the first time. We assume that plasma concentration of<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M10"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CoQ</mml:mtext></mml:mrow><mml:mrow><mml:mn mathvariant="normal">10</mml:mn><mml:mo>-</mml:mo><mml:mtext>TOTAL</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:math>and lipid peroxidation could be used as relevant biomarkers of ubiquinol supportive therapy.</jats:p> |
| doi_str_mv | 10.1155/2014/798957 |
| facet_avail | Online, Free |
| finc_class_facet | Biologie, Chemie und Pharmazie |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1NS8yMDE0Lzc5ODk1Nw |
| imprint | Hindawi Limited, 2014 |
| imprint_str_mv | Hindawi Limited, 2014 |
| institution | DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1 |
| issn | 1942-0900, 1942-0994 |
| issn_str_mv | 1942-0900, 1942-0994 |
| language | English |
| last_indexed | 2024-03-01T17:37:16.363Z |
| match_str | gvozdjakova2014ubiquinolimprovessymptomsinchildrenwithautism |
| mega_collection | Hindawi Limited (CrossRef) |
| physical | 1-6 |
| publishDate | 2014 |
| publishDateSort | 2014 |
| publisher | Hindawi Limited |
| record_format | ai |
| recordtype | ai |
| series | Oxidative Medicine and Cellular Longevity |
| source_id | 49 |
| spelling | Gvozdjáková, Anna Kucharská, Jarmila Ostatníková, Daniela Babinská, Katarína Nakládal, Dalibor Crane, Fred L. 1942-0900 1942-0994 Hindawi Limited Cell Biology Aging General Medicine Biochemistry http://dx.doi.org/10.1155/2014/798957 <jats:p><jats:italic>Background</jats:italic>. Autism is a spectrum of neurodevelopmental disorders with manifestation within 3 years after birth. Manifestations of autism include behavior problems (hyperactivity, toys destruction, self-harm, and agression) and sleep and eating disorders. Etiology of autism is poorly understood. Oxidative stress and antioxidants can participate in pathobiochemical mechanisms of autism.<jats:italic>Methods</jats:italic>. Twenty-four children, aged 3–6 years, with autism according to the DSM IV criteria and using CARS were included in the study. Concentrations of<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CoQ</mml:mtext></mml:mrow><mml:mrow><mml:mn mathvariant="normal">10</mml:mn><mml:mo>-</mml:mo><mml:mtext>TOTAL</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:math>,<jats:italic>γ</jats:italic>- and<jats:italic>α</jats:italic>-tocopherol,<jats:italic>β</jats:italic>-carotene, and lipid peroxidation were determined in plasma before and after three months of supportive therapy with ubiquinol at a daily dose<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M2"><mml:mn>2</mml:mn><mml:mo>×</mml:mo><mml:mn>50</mml:mn></mml:math> mg. Data on behavior of the children were collected from parents at the same time.<jats:italic>Results</jats:italic>. Ubiquinol supportive therapy improved symptoms in children with autism, as communication with parents (in<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M3"><mml:mn>12</mml:mn><mml:mi>%</mml:mi></mml:math>), verbal communication (in<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M4"><mml:mn>21</mml:mn><mml:mi>%</mml:mi></mml:math>), playing games of children (in<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M5"><mml:mn>42</mml:mn><mml:mi>%</mml:mi></mml:math>), sleeping (in<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M6"><mml:mn>34</mml:mn><mml:mi>%</mml:mi></mml:math>), and food rejection (in<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M7"><mml:mn>17</mml:mn><mml:mi>%</mml:mi></mml:math>), with<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M8"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CoQ</mml:mtext></mml:mrow><mml:mrow><mml:mn mathvariant="normal">10</mml:mn><mml:mo>-</mml:mo><mml:mtext>TOTAL</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:math>plasma level above<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M9"><mml:mn>2.5</mml:mn><mml:mo> </mml:mo><mml:mi>μ</mml:mi><mml:mtext>mol</mml:mtext><mml:mo>/</mml:mo><mml:mtext>L</mml:mtext></mml:math>.<jats:italic>Conclusions</jats:italic>. Beneficial effect of ubiquinol in children with autism has been demonstrated for the first time. We assume that plasma concentration of<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M10"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CoQ</mml:mtext></mml:mrow><mml:mrow><mml:mn mathvariant="normal">10</mml:mn><mml:mo>-</mml:mo><mml:mtext>TOTAL</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:math>and lipid peroxidation could be used as relevant biomarkers of ubiquinol supportive therapy.</jats:p> Ubiquinol Improves Symptoms in Children with Autism Oxidative Medicine and Cellular Longevity |
| spellingShingle | Gvozdjáková, Anna, Kucharská, Jarmila, Ostatníková, Daniela, Babinská, Katarína, Nakládal, Dalibor, Crane, Fred L., Oxidative Medicine and Cellular Longevity, Ubiquinol Improves Symptoms in Children with Autism, Cell Biology, Aging, General Medicine, Biochemistry |
| title | Ubiquinol Improves Symptoms in Children with Autism |
| title_full | Ubiquinol Improves Symptoms in Children with Autism |
| title_fullStr | Ubiquinol Improves Symptoms in Children with Autism |
| title_full_unstemmed | Ubiquinol Improves Symptoms in Children with Autism |
| title_short | Ubiquinol Improves Symptoms in Children with Autism |
| title_sort | ubiquinol improves symptoms in children with autism |
| title_unstemmed | Ubiquinol Improves Symptoms in Children with Autism |
| topic | Cell Biology, Aging, General Medicine, Biochemistry |
| url | http://dx.doi.org/10.1155/2014/798957 |